{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:52:40Z","timestamp":1781013160248,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.trsl.2011.12.003","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T16:51:59Z","timestamp":1325609519000},"page":"477-486","source":"Crossref","is-referenced-by-count":114,"title":["Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"159","author":[{"given":"Federico","family":"Salamone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Galvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mangiameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Li Volti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2011.12.003_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.trsl.2011.12.003_bib2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2011.12.003_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.23741","article-title":"Treating fatty liver for the prevention of cardiovascular diseases","volume":"52","author":"Salamone","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2011.12.003_bib4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2011.12.003_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2009.07.008","article-title":"Histopathology of non-alcoholic fatty liver disease","volume":"13","author":"Brunt","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.trsl.2011.12.003_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","article-title":"Fatty liver and lipotoxicity","volume":"1801","author":"Trauner","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2011.12.003_bib7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.freeradbiomed.2007.12.029","article-title":"Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases","volume":"44","author":"Mantena","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2011.12.003_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.2007.141986","article-title":"Nuclear factor-kappaB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy","volume":"57","author":"Marra","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2011.12.003_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2011.12.003_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2004.08.010","article-title":"Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice","volume":"41","author":"Leclercq","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2011.12.003_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(94)90053-1","article-title":"Scavenging of reactive oxygen species by silibinin dihemisuccinate","volume":"48","author":"Mira","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2011.12.003_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.510230415","article-title":"Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin","volume":"23","author":"Dehmlow","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2011.12.003_bib13","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0016-5085(95)90762-9","article-title":"Antioxidant activity of silybin in\u00a0vivo during long-term iron overload in rats","volume":"109","author":"Pietrangelo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2011.12.003_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(03)00239-3","article-title":"Silibinin protects mice from T cell-dependent liver injury","volume":"39","author":"Schumann","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2011.12.003_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1475-2840-10-62","article-title":"Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice","volume":"10","author":"Li Volti","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.trsl.2011.12.003_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/gut.2006.091967","article-title":"A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations","volume":"55","author":"Federico","year":"2006","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2011.12.003_bib17","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1016\/S0168-8278(11)60827-1","article-title":"Silybin conjugated with phosphatidylcholine and vitamin E improves liver damage in patients with NAFLD: the results of a randomized multicentre double-blind vs placebo trial","volume":"54","author":"Andreone","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2011.12.003_bib18","doi-asserted-by":"crossref","first-page":"G1035","DOI":"10.1152\/ajpgi.00199.2004","article-title":"Obese and diabetic db\/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin","volume":"287","author":"Sahai","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2011.12.003_bib19","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2011.12.003_bib20","first-page":"193","article-title":"A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos)","volume":"10","author":"Kidd","year":"2005","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.trsl.2011.12.003_bib21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2008.07.072","article-title":"Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon\/ribavirin therapy","volume":"135","author":"Ferenci","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2011.12.003_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/MCG.0b013e31815cff36","article-title":"Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C","volume":"42","author":"Bares","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2011.12.003_bib23","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/oxfordjournals.jbchem.a132918","article-title":"Purification and properties of acyl-CoA oxidase from rat liver","volume":"87","author":"Osumi","year":"1980","journal-title":"J Biochem"},{"key":"10.1016\/j.trsl.2011.12.003_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0003-2697(85)90434-8","article-title":"Extraction of tissue long-chain acyl-CoA esters and measurement by reverse-phase high-performance liquid chromatography","volume":"150","author":"Woldegiorgis","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1016\/j.trsl.2011.12.003_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.trsl.2011.12.003_bib26","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2011.12.003_bib27","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1194\/jlr.M600198-JLR200","article-title":"Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1","volume":"47","author":"Rizki","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2011.12.003_bib28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bcp.2007.09.030","article-title":"The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury","volume":"75","author":"Gyamfi","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2011.12.003_bib29","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cca.2011.04.013","article-title":"The role of oxidative stress in non-alcoholic steatohepatitis","volume":"412","author":"Koek","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trsl.2011.12.003_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trsl.2011.12.003_bib31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2011.12.003_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbadis.2011.01.003","article-title":"Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease","volume":"1812","author":"Gaemers","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2011.12.003_bib33","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.trsl.2011.12.003_bib34","first-page":"CD004996","article-title":"Antioxidant supplements for non-alcoholic fatty liver disease and\/or steatohepatitis","author":"Lirussi","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trsl.2011.12.003_bib35","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/ars.2008.2060","article-title":"Peroxynitrite detoxification and its biologic implications","volume":"10","author":"Trujillo","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.trsl.2011.12.003_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.21313","article-title":"Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob\/ob mice","volume":"44","author":"Garcia-Ruiz","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2011.12.003_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1005512014280","article-title":"Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils. The effect of silybin","volume":"32","author":"Masini","year":"2000","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.trsl.2011.12.003_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/jpet.109.161612","article-title":"A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis","volume":"332","author":"Serviddio","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2011.12.003_bib39","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1089\/ars.2009.2463","article-title":"Redox regulation of nuclear post-translational modifications during NF-kappaB activation","volume":"11","author":"Gloire","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.trsl.2011.12.003_bib40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2011.12.003_bib41","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1572-0241.2004.40009.x","article-title":"Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients","volume":"99","author":"Ribeiro","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.trsl.2011.12.003_bib42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/oby.2008.601","article-title":"Liver NF-kappaB and AP-1 DNA binding in obese patients","volume":"17","author":"Videla","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.trsl.2011.12.003_bib43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","article-title":"NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis","volume":"129","author":"Dela","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2011.12.003_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/gut.2007.134288","article-title":"Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis","volume":"57","author":"Beraza","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2011.12.003_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2011.12.003_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.302.1.138","article-title":"Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages","volume":"302","author":"Kang","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524411004300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524411004300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T09:21:16Z","timestamp":1543310476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524411004300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1931524411004300"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2011.12.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}